Full Text View
Tabular View
No Study Results Posted
Related Studies
A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee
This study has been completed.
Study NCT00568295   Information provided by Johnson & Johnson Consumer and Personal Products Worldwide

First Received on December 4, 2007.   Last Updated on August 19, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis of the Knee
Additional conditions recognized in this trial
Osteoarthritis
Osteoarthritis, Knee
More general conditions related to this trial
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
acetaminophen
Rofecoxib
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antipyretics
Antirheumatic Agents
Central Nervous System Agents
Cyclooxygenase 2 Inhibitors
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Johnson & Johnson Consumer and Personal Products Worldwide


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services